Older age not linked to increased risk for Crohn’s recurrence after surgical resection

SAN DIEGO — The risk for postoperative recurrence of Crohn’s disease after ileocolic resection did not increase among older patients compared with a younger cohort, according to research presented at Digestive Disease Week 2022.“Despite the advances of medical therapy, the need for surgical intervention [for CD] is still quite significant with more recent estimates placing the 10-year risk for surgery at around 25%. … As we know from the PREVENT trial and other studies, [anti-tumor necrosis factor] and presumably other post-op biologics reduce the risk of endoscopic recurrence,”Read More

Categories: News

Related Articles

Biologics linked to lower dementia rate in older patients with IBD

SAN DIEGO — Older patients with inflammatory bowel disease who were treated with biologics exhibited a lower incidence of dementia compared with those never treated…

TNF inhibitors less effective for older-onset IBD patients

Anti-tumor necrosis factor therapy had reduced efficacy and safety for bio-naive patients with older-onset inflammatory bowel disease compared with younger patients, according to a study…

Vedolizumab, ustekinumab best anti-TNF for infection risk in older adult IBD

SAN DIEGO — Vedolizumab and ustekinumab associated with a lower risk for infection-related hospitalizations compared with anti-tumor necrosis factor agents in patients who initiated inflammatory…

Anti-TNF, surgical closure induces long-term healing in Crohn’s fistulas

Short-term anti-tumor necrosis factor treatment combined with surgical closure induced long-term MRI healing in patients with Crohn’s perianal fistulas more frequently than anti-TNF therapy alone,…

TNF inhibitors pose ‘modest risk’ for new-onset psoriasis

Patients with immune mediated diseases and treated with tumor necrosis factor-alpha inhibitors have a modest risk for new onset psoriasis, according to a study.“Biologics are…